Pelvic cancer is a serious disease that needs advanced, well coordinated medical care. Germany has become a preferred destination for patients looking for both traditional and innovative approaches to treatment.
Pelvic cancer is a serious disease that needs advanced, well coordinated medical care. Germany has become a preferred destination for patients looking for both traditional and innovative approaches to treatment. Hospitals in Germany use modern imaging systems, targeted therapy options, and highly experienced oncology teams. The aim is to control tumor growth, reduce symptoms, and maintain quality of life.
International patients often choose Germany for treatments such as dendritic cell therapy for pelvic cancer and TACP therapy. Both treatments are performed by leading specialists and supported by strong clinical results.
Innovative or targeted treatment options in Germany are:
TACP treatment in Germany by Thomas Vogl
Dendritic cell therapy treatment in Germany by Prof. Dr. Frank Gansauge
Chemotherapy for advanced or widespread disease
Radiation therapy for symptom relief or tumor reduction
Combination therapy for complex cases
How TACP Works
TACP therapy in Germany (transarterial chemoperfusion), is a targeted, minimally invasive treatment performed in specialized interventional radiology centers. During the procedure, a thin catheter is inserted into an artery leading to the pelvic tumor. Through this catheter, a concentrated dose of chemotherapy drugs is delivered directly into the tumor’s blood supply. Special embolic agents are then used to block the vessels feeding the tumor. This traps the drug in the tumor and cuts off its nutrient supply.
This approach allows a high concentration of the chemotherapy to act on the tumor while sparing healthy tissue. Side effects are usually milder than those from systemic chemotherapy. The procedure can be repeated several times, depending on tumor response and patient condition.
Germany is known for excellence in interventional radiology frankfurt and personalized treatment planning. Hospitals are equipped with advanced imaging and monitoring technology, enabling precise targeting during TACP therapy. Prof. Dr. Thomas J. Vogl, a leading radiologist in Frankfurt and head of the Institute for Diagnostic and Interventional Radiology at University Hospital Frankfurt, is one of the most experienced specialists in this field. He has refined TACP methods to improve safety and effectiveness.
Patients from around the world contact TIG (www.treatmentingermany.com) for appointment booking with Prof. Dr. Vogl. Services include medical record review, travel arrangements, and coordination of treatment schedules.
TACP Therapy Success Rate in Germany
The TACP therapy success rate in Germany depends on the size, location, and stage of the tumor, as well as the patient’s general health. For many patients with advanced or inoperable pelvic tumors, TACP achieves significant tumor shrinkage or stabilization. In stage 4 pelvic cancer treatment in Germany, it can slow disease progression, improve symptoms, and extend survival time.
Cost of TACP Therapy for Pelvic Cancer in Germany
The cost for TACP treatment in Germany is generally between 8,000 and 9,000 EUR per session. This includes the procedure itself, hospital stay, required medications, follow-up imaging, and all necessary logistical support.
Prof. Dr. Thomas J. Vogl: Leading Radiologist in Germany
Prof. Dr. Thomas J. Vogl is an internationally recognized expert in interventional oncology. With thousands of procedures performed, he has contributed to major improvements in targeted drug delivery and embolization techniques. Many patient testimonials of Prof Vogl highlight his ability to explain treatment options clearly, his careful technique, and his commitment to achieving the best possible outcomes.
Prof. Dr. Thomas J. Vogl has authored over a hundred scientific publications in renowned medical and research journals.
Dendritic Cell Therapy for Pelvic Cancer in Germany
How Dendritic Cell Therapy Works
Dendritic cell therapy in Germany is an advanced immunotherapy designed to train the body’s own immune system to recognize and attack cancer cells. The process starts with collecting blood from the patient to isolate dendritic cells, which are key immune cells responsible for identifying harmful cells.
In the laboratory, these dendritic cells are exposed to tumor-specific antigens so they can “learn” to recognize the cancer. Once activated, the cells are reintroduced into the patient’s body through injections. This stimulates T-cells and other immune responses to attack the tumor.
Unlike chemotherapy, dendritic cell therapy targets only cancer cells, preserving healthy tissue and reducing treatment-related side effects.
Why Dendritic Cell Therapy is Offered in Germany
Germany is a leader in personalized cancer vaccine development. Prof. Dr. Frank Gansauge, based in Berg, is an expert in immunotherapy and has developed highly effective dendritic cell protocols. His clinic is known for tailoring treatment to the individual patient’s tumor profile.
Patients from countries like US where the dendritic cell cancer vaccine is not available often travel to Germany to receive this treatment. The process involves a complete medical evaluation, laboratory preparation of the dendritic cells, administration of the therapy, and careful follow-up.
Dendritic Cell Therapy Success Rate in Germany
The dendritic cell therapy success rate in Germany depends on factors such as cancer stage, the patient’s immune system function, and whether the therapy is combined with treatments like TACP. Many patients experience stronger immune responses, slower tumor growth, and, in some cases, reduction in tumor size.
Cost of Dendritic Cell Therapy in Germany
The dendritic cell therapy in Germany cost is usually 23,000 to 24,000 EUR. This price covers immune profiling, lab preparation, antigen training, vaccine injections, and follow-up consultations and all necessary logistical support.
Prof. Dr. Frank Gansauge: Expert in Immunotherapy
Prof. Dr. Frank Gansauge has decades of experience in cancer immunology. He treats patients from around the world and is known for offering highly personalized treatment and thorough patient support. His clinic is one of the most trusted places for dendritic cell therapy for pelvic cancer in Germany.
Prof. Dr. Frank Gansauge has authored over a hundred scientific publications in renowned medical and research journals.
Comparison of Innovative Pelvic Cancer Treatments in Germany
|
Treatment Type |
Mechanism |
Cost Range |
Key Specialists |
Suitable for |
|
TACP Therapy |
Chemotherapy drugs delivered directly into tumor artery with embolization to block blood supply |
8,000–9,000 EUR per session |
Prof. Dr. Thomas J. Vogl, Frankfurt |
Patients with non-resectable pelvic tumors |
|
Dendritic Cell Therapy |
Laboratory-activated immune cells target and attack tumor cells |
23,000–24,000 EUR total |
Prof. Dr. Frank Gansauge, Berg |
Patients seeking advanced immunotherapy options (Cancer Vaccines) |
Other Available Treatments for Pelvic Cancer in Germany
Chemotherapy: Given when cancer has spread beyond the pelvis, targeting rapidly dividing cells.
Radiation therapy: Focused high-energy rays to shrink tumors or relieve pain.
Surgical resection: Considered for early-stage cases with good overall health.
🌍Why Patients Worldwide Prefer Our Medical Services in Germany – Key Benefits Explained:
Frequently Asked Questions
How long does a person live with stage 4 pelvic cancer?
Life expectancy depends on tumor spread, overall health, and treatment choice. TACP therapy and dendritic cell therapy in Germany often help extend life compared to no treatment.
Can pelvic cancer be cured?
Advanced pelvic cancer is rarely cured, but modern treatments can control disease and improve quality of life.
Can pelvic cancer cause weight gain?
Yes, due to fluid buildup or treatment effects.
Can pelvic cancer be genetic?
Some cases have genetic links, but most develop from other risk factors.
How can pelvic cancer spread?
It can spread through the bloodstream, lymphatic system, or direct invasion into nearby organs.
When cancer metastasizes is it treatable?
Yes, with targeted options like TACP in Germany or immunotherapy.
Will cancer show up in blood work?
Some markers may appear in blood tests, but imaging and biopsy confirm the diagnosis.
Is dendritic cell therapy approved by FDA?Sipuleucel-T (Provenge) for advanced prostate cancer, is FDA-approved; all others are still experimental.
Best oncologist in Germany for pelvic cancer?
Germany has several top sarcoma centers with expert teams; the best choice depends on the patient’s case, location, and treatment needs.
Contact us through TIG (www.treatmentingermany.com) for assistance with consultation, scheduling, and treatment planning in Germany.
Kindly complete the form below, and our dedicated team will reach out to you promptly. We look forward to connecting with you soon!
Trierer Straße, 56072 Koblenz, Germany
